Ligong Lu

214 papers and 5.1k indexed citations i.

About

Ligong Lu has authored 214 papers that have received a total of 5.1k indexed citations. This includes 63 papers in Molecular Biology, 62 papers in Hepatology and 48 papers in Oncology. The topics of these papers are Hepatocellular Carcinoma Treatment and Prognosis (55 papers), Nanoplatforms for cancer theranostics (32 papers) and Cancer Mechanisms and Therapy (20 papers). Ligong Lu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (55 papers), Nanoplatforms for cancer theranostics (32 papers) and Cancer Mechanisms and Therapy (20 papers) and collaborates with scholars based in China, United States and Macao. Ligong Lu's co-authors include Meixiao Zhan, Xu He, Bao‐Shan Hu and Sirui Fu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Nature Medicine.

In The Last Decade

Fields of papers published by Ligong Lu

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

Countries citing papers authored by Ligong Lu

Since Specialization
Citations
Rankless by CCL
2025